Phase I trial of novel CAR-T cell therapy for pediatric midline gliomas
1. Approximately 88% of patients with GD2-positive diffuse midline glioma or other progressive CNS tumours receiving C7R-GD2.CARTs had a partial ...
Tag: brain cancer
The 2 Minute Medicine Podcast Episode 38
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: Patient Zero: Immunotherapy for Brain Tumors?, Over-the-Counter Birth Control, Florida Supreme Court Deals a Devastating Blow to Abortion Access, Schwarzenegger’s Post-Pacemaker Update on Instagram
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Penetrating traumatic brain injuries associated with greater risk of brain cancer amongst veterans
1. Among United States veterans of the Iraq and Afghanistan wars, the experience of a moderate, severe, or penetrating traumatic ...
CAR-T Cell Therapy for Relapsed or Refractory High-Risk Neuroblastoma
1. GD2-CART01 infusion had an overall response of 63% of patients (33% complete response) with a 3-year overall survival of ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
